Liver King TRT: What He Actually Admitted and How It Compares to Similar Public Figures

At a glance
- Admission date / December 2022 public YouTube apology
- Compounds admitted / Testosterone, HGH, IGF-1, and multiple anabolic steroids per leaked emails
- Estimated monthly spend / ~$11,000 USD on PEDs per leaked email documents
- Legal trigger / Class-action lawsuit by consumers who purchased his supplement products
- Comparison category / High-profile fitness influencers and podcasters who have discussed TRT or PED use
- Clinical concern / Unsupervised supraphysiologic dosing carries cardiovascular and endocrine risks
- Guideline standard / FDA-approved TRT is indicated only for confirmed hypogonadism (serum testosterone <300 ng/dL per AUA 2018)
- Key distinction / Therapeutic TRT differs substantially from the supraphysiologic stacks described in his leaked protocol
What Liver King Actually Admitted
Liver King's December 2022 apology video on YouTube marked a clear break from years of claiming his physique was built without performance-enhancing drugs. The admission came after leaked emails, reported by fitness YouTuber Derek of More Plates More Dates, detailed a monthly PED budget of approximately $11,000 and a protocol that included testosterone, human growth hormone, IGF-1, insulin, and additional anabolic compounds.
The Leaked Protocol in Detail
The emails, which Johnson did not dispute, described a stack that went well beyond what any physician would prescribe for hypogonadism. Per those documents, the protocol included:
- Testosterone (form unspecified in leaks, but consistent with injectable esters commonly used in supraphysiologic cycles)
- Recombinant human growth hormone (rHGH)
- IGF-1 (insulin-like growth factor-1)
- Insulin
- Additional unnamed anabolic-androgenic steroids
Supraphysiologic testosterone dosing, meaning doses that push serum levels far above the normal male range of 300 to 1,000 ng/dL, is associated with left ventricular hypertrophy, dyslipidemia, erythrocytosis, and suppression of the hypothalamic-pituitary-gonadal axis. A 2023 review in the Journal of the American College of Cardiology confirmed that non-prescribed anabolic-androgenic steroid use is independently associated with impaired systolic function and accelerated coronary artery disease.
What He Said Publicly
In his apology video, Johnson stated: "I've been doing TRT and more." He framed the admission as incomplete at first, then acknowledged that what he had been doing extended far beyond standard testosterone replacement therapy. That framing matters clinically. Therapeutic TRT, as defined by the 2018 American Urological Association guideline, targets a restoration of serum testosterone to the mid-normal physiologic range for age, not the supraphysiologic levels implied by a protocol of the complexity described in the leaks.
The AUA's 2018 guideline on testosterone deficiency states that treatment is indicated for men with symptoms of hypogonadism and a confirmed morning serum total testosterone below 300 ng/dL on two separate measurements. Nothing in the leaked protocol or Johnson's admission suggests a diagnosis-driven, monitored course of care.
The Clinical Difference Between TRT and What Johnson Described
This distinction is not semantic. Therapeutic TRT and a bodybuilding-grade PED stack operate through overlapping but very different mechanisms, carry different risk profiles, and exist in entirely different regulatory and medical contexts.
FDA-Approved TRT: What It Is
FDA-approved testosterone formulations, including testosterone cypionate injection (Depo-Testosterone), testosterone enanthate (Xyosted), transdermal gels (AndroGel, Testim), and the nasal gel Natesto, are indicated for male hypogonadism confirmed by laboratory testing. The FDA's prescribing information for testosterone cypionate specifies dosing ranges and monitoring requirements including hematocrit checks and lipid panels.
Typical therapeutic dosing with testosterone cypionate runs 50 to 200 mg every one to two weeks, with the goal of maintaining trough serum testosterone in the 400 to 700 ng/dL range. Monitoring at three and six months post-initiation, then annually, is standard under most clinical protocols.
What Supraphysiologic Stacking Does
Adding rHGH, IGF-1, and insulin to testosterone creates compounding anabolic signals that no monitored TRT protocol includes. A 2020 systematic review in the Cochrane Database of Systematic Reviews found that exogenous GH use in healthy adults produces modest increases in lean body mass but is associated with fluid retention, carpal tunnel syndrome, glucose intolerance, and possible promotion of neoplastic growth in susceptible individuals. Combining GH with insulin amplifies hypoglycemia risk substantially.
The cardiovascular consequences of long-term supraphysiologic androgens are well-documented. Baggish et al. (2017, Circulation) studied 140 male weightlifters and found that long-term AAS users had significantly reduced left ventricular ejection fraction (52% vs. 63% in non-users, P<0.001) and higher prevalence of diastolic dysfunction.
How Liver King's Disclosure Compares to Similar Public Figures
Several high-profile men in the fitness, podcast, and wellness space have spoken publicly about testosterone or hormone use. Their disclosures vary widely in specificity, clinical framing, and the degree to which they distinguish therapeutic use from performance enhancement.
Joe Rogan
Joe Rogan has discussed TRT, HGH, and testosterone on his podcast multiple times over more than a decade. He has consistently framed his use as medically supervised, mentioning working with physicians and undergoing lab monitoring. In a 2021 episode, Rogan stated he uses testosterone, HGH, and has taken semaglutide for weight management. He has not disclosed specific doses but has described the goal as "optimizing" hormone levels rather than achieving supraphysiologic physique changes. That framing is meaningfully different from what Johnson's leaked emails described.
The clinical legitimacy of "optimization" framing in men with normal baseline testosterone remains contested. A 2020 editorial in JAMA Internal Medicine noted that testosterone prescribing in men without confirmed hypogonadism has grown substantially since 2000, driven partly by direct-to-consumer marketing and "low-T" campaigns, and cautioned that benefits in eugonadal men remain unproven while risks persist.
Andrew Huberman
Stanford neuroscientist Andrew Huberman has discussed testosterone optimization on his podcast and acknowledged past testosterone use. He has been more measured in his disclosures than either Rogan or Johnson, emphasizing lifestyle interventions (sleep, resistance training, sunlight exposure) as primary tools and framing any hormonal support as secondary. He has not, to date, faced allegations comparable to Johnson's that his publicly claimed lifestyle was a cover for a concealed PED stack.
Derek (More Plates More Dates)
Derek, the YouTuber who broke the Liver King story, occupies a different position. He has been transparent about his own extensive research-chemical and performance-enhancement history and frames his channel explicitly around PED education, not ancestral health branding. His exposure of Johnson's emails was significant precisely because it contradicted Johnson's commercial positioning. The contrast matters: Derek never claimed to be achieving his results without pharmacological assistance.
The Pattern Across These Cases
The comparison across these figures reveals a consistent spectrum of disclosure quality. At one end sits explicit, verified admission tied to legal pressure (Johnson). At the other sits ongoing ambiguity wrapped in "optimization" language with no disclosed lab values or monitoring protocols (most fitness podcasters). True therapeutic TRT in a supervised clinical setting sits off that spectrum entirely because it involves documented indication, baseline labs, dose titration, and follow-up monitoring, none of which these public disclosures typically include.
A useful framework for evaluating any public figure's hormone disclosure:
- Is there a documented clinical indication (e.g., serum testosterone <300 ng/dL)?
- Are doses described in therapeutic ranges or performance ranges?
- Is ongoing monitoring (hematocrit, PSA, lipids, LH/FSH) mentioned?
- Has the person disclosed the full compound list, not just testosterone?
Johnson's leaked emails fail all four criteria. Most podcast-based disclosures address none of them.
The Supplement and Legal Dimension
Johnson's PED admission was not purely reputational. A class-action lawsuit filed in federal court in 2022 alleged that consumers purchased his supplement products based on the representation that his physique was achievable through ancestral nutrition alone. The legal theory was that Johnson's undisclosed PED use constituted deceptive marketing. That suit settled in 2023.
This adds a dimension absent from most celebrity TRT conversations. When a public figure's supplement revenue depends on the credibility of a particular lifestyle claim, undisclosed PED use takes on the character of commercial fraud, not merely personal health choice.
The FTC's guidelines on endorsements and testimonials require that material connections between endorsers and products be disclosed and that endorsements not misrepresent the endorser's experience with a product or lifestyle. Johnson's admitted gap between public persona and private practice sat squarely in that territory.
What the Physique Science Actually Shows
Johnson's core claim, that eating raw liver, testes, and bone marrow while doing cold plunges and sunrise walks could produce an elite bodybuilder's physique in a man over 40, conflicts directly with the exercise science and endocrinology literature.
Natural Anabolic Ceiling
A 2020 review in the Journal of Strength and Conditioning Research estimated that drug-free male athletes can gain approximately 0.5 to 1 kg of lean mass per month under optimal training and nutrition conditions, with total achievable lean mass in experienced trainees plateauing well below the muscle mass observable in elite-level bodybuilders or Johnson's documented physique.
Dietary organ meat provides high-quality protein and micronutrients including vitamin B12, retinol, and heme iron. None of these nutrients have any demonstrated ergogenic effect on muscle hypertrophy at the level Johnson's physique would require. The NIH Office of Dietary Supplements fact sheet on iron confirms iron supports oxygen transport and exercise performance in deficient individuals but produces no additional benefit above sufficiency.
Age and Endogenous Testosterone
Men over 40 experience a gradual decline in endogenous testosterone production, averaging roughly 1 to 2% per year after age 30 per Harman et al. (2001, Journal of Clinical Endocrinology and Metabolism). Johnson was in his mid-40s during the height of his brand's growth. The probability of maintaining the muscle mass and body fat percentage he displayed through lifestyle alone, without exogenous androgens, is inconsistent with what endocrinology literature documents as physiologically possible in that age range.
HGH and Body Composition at Age 40+
Exogenous rHGH does produce measurable body composition changes. A 1990 NEJM study by Rudman et al. (N=21) found that GH administration in men over 60 reduced adipose tissue mass and increased lean body mass, but the cardiovascular and metabolic risks, along with the modest magnitude of effect, have tempered clinical enthusiasm for GH outside of confirmed GH deficiency. The combination of rHGH with supraphysiologic testosterone would amplify both the anabolic effect and the risk profile.
Clinical Implications for Patients Encountering This Content
Patients who follow influencers in the ancestral health, carnivore, or "ancestral living" space may encounter claims that lifestyle interventions alone can produce dramatic body composition changes, normalize low testosterone, or reverse age-related hormonal decline. The Liver King case is the most documented example of those claims being commercially funded and chemically supported rather than genuinely lifestyle-derived.
What to Discuss With a Clinician
Men who are curious about testosterone optimization or who have symptoms consistent with hypogonadism (fatigue, low libido, reduced morning erections, decreased lean mass, mood changes) should seek evaluation through a licensed provider. The starting point is a morning serum total testosterone drawn before 10 a.m. On two separate days, along with LH, FSH, prolactin, and SHBG to contextualize the free testosterone fraction. The Endocrine Society's 2018 clinical practice guideline on testosterone therapy recommends against testosterone therapy in men who have not had biochemical confirmation of hypogonadism.
Dietary liver and organ meats carry genuine nutritional value and are worth including in a varied diet. Retinol content in beef liver is high enough that daily large servings can approach or exceed the tolerable upper intake level of 3,000 mcg RAE per day for adults per NIH ODS vitamin A fact sheet. That is a real clinical consideration, not an ancestral health talking point.
Red Flags in Supplement Marketing
Any supplement or program that implies its results are achievable purely through the product when the spokesperson's physique is driven by undisclosed pharmacology represents a misleading basis for a purchasing decision. Patients should ask three questions before buying physique-oriented supplements endorsed by public figures:
- Has the endorser disclosed full lab work and any pharmaceutical or hormonal use?
- Is the physique shown consistent with what peer-reviewed literature documents as achievable without pharmacological assistance?
- Does the company publish any randomized controlled trial data on its own products?
Johnson's supplements were never supported by peer-reviewed efficacy data. The FTC lawsuit settlement underscores the legal exposure that attaches to physique-based supplement marketing built on undisclosed PED use.
Monitoring Parameters for Men on Legitimate TRT
For men who do have confirmed hypogonadism and are prescribed testosterone by a licensed provider, the monitoring schedule recommended by the Endocrine Society 2018 guideline includes:
- Serum testosterone at three and six months post-initiation, then annually
- Hematocrit at baseline, three to six months, then annually (hold or reduce dose if hematocrit exceeds 54%)
- PSA at baseline and at three to six months in men over 40
- Bone mineral density at one to two years in men with osteoporosis or low trauma fracture history
- Lipid panel at baseline and annually given modest reductions in HDL-C observed with testosterone therapy
None of these monitoring steps appear in any publicly known protocol associated with Johnson's admitted use. That gap, between unsupervised supraphysiologic stacking and monitored physiologic replacement, is the central clinical lesson of the Liver King disclosure.
Frequently asked questions
›Does Liver King take TRT medication?
›What did Liver King actually admit to taking?
›Why did Liver King come out about steroid use?
›How does Liver King's PED use compare to Joe Rogan's?
›Is eating raw liver enough to raise testosterone naturally?
›What is the difference between TRT and steroids?
›Can a man over 40 build a bodybuilder physique naturally?
›What compounds did the Liver King leaked emails mention?
›Should I take organ meat supplements for testosterone?
›How is legitimate TRT monitored?
›Did Liver King face legal consequences for his supplement claims?
References
- Baggish AL, Weiner RB, Kanayama G, et al. Cardiovascular Toxicity of Illicit Anabolic-Androgenic Steroid Use. Circulation. 2017;135(21):1991-2002. https://pubmed.ncbi.nlm.nih.gov/27789571/
- Bhasin S, Brito JP, Cunningham GR, et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. https://pubmed.ncbi.nlm.nih.gov/29562364/
- Rudman D, Feller AG, Nagraj HS, et al. Effects of Human Growth Hormone in Men over 60 Years Old. N Engl J Med. 1990;323(1):1-6. https://pubmed.ncbi.nlm.nih.gov/2355952/
- Harman SM, Metter EJ, Tobin JD, Pearson J, Blackman MR. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. J Clin Endocrinol Metab. 2001;86(2):724-731. https://pubmed.ncbi.nlm.nih.gov/11502822/
- Liu H, Bravata DM, Olkin I, et al. Systematic review: the safety and efficacy of growth hormone in the healthy elderly. Ann Intern Med. 2007;146(2):104-115. https://pubmed.ncbi.nlm.nih.gov/17227934/
- Cochrane Database of Systematic Reviews. Growth hormone for improving athletic performance. 2020. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013429.pub2
- Fink J, Schoenfeld BJ, Nakazato K. The role of hormones in muscle hypertrophy. Phys Sportsmed. 2018;46(1):129-134. https://pubmed.ncbi.nlm.nih.gov/28834797/
- Vigen R, O'Donnell CI, Baron AE, et al. Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels. JAMA. 2013;310(17):1829-1836. https://pubmed.ncbi.nlm.nih.gov/24193080/
- Schwartz LM, Woloshin S. Medical Marketing in the United States, 1997-2016. JAMA. 2019;321(1):80-96. https://pubmed.ncbi.nlm.nih.gov/31657845/
- Testosterone Cypionate Injection, USP. FDA Prescribing Information. 2018. https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/085635s032lbl.pdf
- National Institutes of Health Office of Dietary Supplements. Vitamin A Fact Sheet for Health Professionals. https://ods.od.nih.gov/factsheets/VitaminA-HealthProfessional/
- National Institutes of Health Office of Dietary Supplements. Iron Fact Sheet for Health Professionals. https://ods.od.nih.gov/factsheets/Iron-HealthProfessional/
- Federal Trade Commission. FTC Endorsement Guides: What People Are Asking. https://www.ftc.gov/business-guidance/resources/ftc-endorsement-guides-what-people-are-asking
- Elagizi A, Köhler TS, Lavie CJ. Testosterone and Cardiovascular Health. Mayo Clin Proc. 2018;93(1):83-100. https://pubmed.ncbi.nlm.nih.gov/29275030/